Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Microbiology test, Peroneal nerve palsy, Stool analysis, Vitamin B12, Weight
Clinical narrative: Lost his ability to walk; could barely walk; could not walk up the hall without significant difficulty; difficulty in walking; CIDP; Lymphocytic colitis; Sick; IBS; Lost weight, almost 25 pounds; Drop foot; Losing his balance; This is a spontaneous report received from a consumer.  A 59-year-old male patient received BNT162b2 (BNT162B2), on 15Oct2021 as dose 3 (booster), single (Lot number: 30155BA) at the age of 57 years, in right deltoid for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1; Lot Number: EK5730; left deltoid), administration date: 22Dec2020, when the patient was 56-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2; Lot Number: EL1283; left deltoid), administration date: 12Jan2021, when the patient was 57-year-old, for COVID-19 immunization. The following information was reported: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (hospitalization, disability, medically significant) with onset Feb2023, outcome "not recovered", described as "CIDP"; BALANCE DISORDER (non-serious) with onset Feb2023, outcome "unknown", described as "Losing his balance"; GAIT INABILITY (hospitalization, disability, medically significant) with onset Mar2023, outcome "unknown", described as "Lost his ability to walk; could barely walk; could not walk up the hall without significant difficulty; difficulty in walking"; COLITIS MICROSCOPIC (medically significant), outcome "unknown", described as "Lymphocytic colitis"; ILLNESS (non-serious), outcome "unknown", described as "Sick"; IRRITABLE BOWEL SYNDROME (non-serious), outcome "recovered", described as "IBS"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "Lost weight, almost 25 pounds"; PERONEAL NERVE PALSY (non-serious), outcome "unknown", described as "Drop foot". The patient was hospitalized for gait inability, chronic inflammatory demyelinating polyradiculoneuropathy (start date: 10May2023, discharge date: 11May2023, hospitalization duration: 2 day(s)). The patient who is a respiratory therapist wanted to know if the company has a program for vaccines for insults because he got sick from the vaccine. Prior to this he was in perfect health never bad laboratory tests in life. As soon as the patient had the vaccine, he had bouts of IBS that lasted 8 to 10 months. He lost weight, almost 25 pounds. He had multiple stool samples with nothing positive showing up. He also had a colonoscopy done showing lymphocytic colitis which is white blood cells attacking his colon, a type of autoimmune disorder. There were no positive infections; nothing came back positive in terms of infection. Shortly afterwards (Feb2023), the patient came down with CIDP (diagnosed on 10May2023). The patient got chronic inflammatory demyelinating polyneuropathy (CIDP) from the vaccine which is a form of Guillen Barre, and it attacked his legs. The patient had started losing his balance in Feb2023 and by Mar2023, he was at work with severe drop foot and could barely walk. He works at a hospital. He could not walk up the hall without significant difficulty. He never had sensation before. The patient has poor balance which leads to extreme difficulty in walking. From his knees down, it's shot. The patient was admitted to a hospital overnight for workup and because he could not walk. The patient had lost his ability to walk. He was only hospitalized one night (10May2023 to 11May2023). They ran every test. He had B12 deficiency test done to rule out Vitamin B12 deficiency. Tested for Lyme disease and came back negative. There were a lot of tests done, he would have to go back and look. There were dozens of them. He had a spinal tap and EMG test done. On the EMG, his ankle showed the myelin sheath and axon to knee with minor damage, has damage with legs. Has minor damage to arms. His arms are not as affected as badly as his legs. As treatment or intervention for CIDP, the patient had 17 IVIg infusions given once every 3 weeks, oral steroids (prednisone) for 8 months, and on IV prednisone for 8 weeks (1000 mg once a week). Currently about the same, but it got worse before it plateaus. Now, the patient wears ankle-foot orthotics (AFOs), they go under his foot. It's still difficult to walk, but if he does not wear AFOs, he could not walk more than 10 to 20 feet without having to sit down. The patient also mentioned a percentage of people are getting cardiac issues from the vaccine.